Literature DB >> 1850376

Natural history and prognostic variables in primary sclerosing cholangitis.

J M Farrant1, K M Hayllar, M L Wilkinson, J Karani, B C Portmann, D Westaby, R Williams.   

Abstract

The clinical features at the time of presentation and the outcome in 126 patients with primary sclerosing cholangitis were studied to clarify the natural history and prognosis in symptomatic and asymptomatic individuals. The median age of the patients at the time of presentation was 36 years, 62% were male, and 16% were asymptomatic. The median follow-up from time of presentation was 5.8 years. There were more patients who had liver transplants (21%) than patients who died of liver-related disease (16%); the estimated median survival to these end points was 12 years. Cholangiocarcinoma was found in 8 patients and in 23% of those undergoing liver transplantation. Asymptomatic patients had milder disease than symptomatic patients, but in a univariate analysis the presence of symptoms was not prognostically significant. On multivariate analysis, the following independent prognostic factors were found: hepatomegaly, splenomegaly, serum alkaline phosphatase, histological stage, and age. These features were combined to produce a prognostic model that should be valuable in the stratification of patients in clinical trials and in the timing of liver transplantation, particularly in those patients seen soon after presentation.

Entities:  

Mesh:

Year:  1991        PMID: 1850376     DOI: 10.1016/0016-5085(91)90673-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  88 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 2.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 3.  Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis.

Authors:  Adolf Stiehl; Daniel Rost
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 4.  Primary sclerosing cholangitis--approach to diagnosis.

Authors:  Ian L Steele; Cynthia Levy; Keith D Lindor
Journal:  MedGenMed       Date:  2007-04-25

5.  Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.

Authors:  S A Mitchell; M Thyssen; T R Orchard; D P Jewell; K A Fleming; R W Chapman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.

Authors:  C Y Ponsioen; S M E Vrouenraets; W Prawirodirdjo; R Rajaram; E A J Rauws; C J J Mulder; J B Reitsma; S H Heisterkamp; G N J Tytgat
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 7.  Primary sclerosing cholangitis: diagnosis and treatment.

Authors:  Holger Lutz; Christian Trautwein; Jens W Tischendorf
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

Review 8.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

Review 9.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

10.  Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.

Authors:  U Broomé; H Glaumann; G Hellers; B Nilsson; J Sörstad; R Hultcrantz
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.